Healio

Q&A: Spinal cord stimulation system offers nonopioid solution to pain management

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Monthly Prescribing Reference

Senza SCS System Approval Expanded to Include Nonsurgical Refractory Back Pain

The Senza SCS System is a neuromodulation device designed to deliver electrical stimulation using implantable leads and a rechargeable, implantable pulse generator. The Food and Drug Administration ...

First-of-its-Kind Study Shows Visibility into Real-Time Spinal Cord Stimulation Utilization and Supports a New Standard of Long-Term Device Management

A new study published in Neuromodulation1 demonstrates that automatic, daily remote monitoring of spinal cord stimulation (SCS) devices enables the first real-time visibility into post-implant therapy ...
Business Wire

St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option

“The approval of the Proclaim Elite recharge-free SCS system is a needed advancement for both patients and physicians who now have access to a low-maintenance chronic pain treatment that can reduce ...
Morningstar

New Data Show Significant Pain Relief, Reduced Opioid Use, Decreased Patient Time and Cost Burdens with the ProsperaTM SCS System

24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...
Business Wire

Nalu Medical, Inc., Announces Positive Results of US Spinal Cord Stimulation Clinical Study in Pain Physician Journal

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc (“Nalu”) is a Carlsbad, California-based company that has successfully miniaturized neurostimulation implants for the management of chronic ...
Nasdaq

Abbott's (ABT) Eterna SCS System Receives FDA's Approval

Abbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS) system for treating chronic pain. The Eterna SCS system is the smallest implantable, rechargeable ...
Monthly Prescribing Reference

Abbott’s SCS System Cleared for Patients With Painful Diabetic Peripheral Neuropathy

It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...
Nasdaq

Abbott (ABT) Expands in Canada With First Eterna SCS Use

Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...
Fast Company

The non-opioid solution driving the next era of pain management

In January 1999, Marianne, a nurse in Houston, Texas, was helping coworkers lift a patient when she felt a twinge in her back. At first, she believed the pain she felt was nothing more than a tweaked ...
Healio

FDA approves spinal cord stimulation system for chronic, nonsurgical back pain

Please provide your email address to receive an email when new articles are posted on . Abbott has announced the FDA expanded the indication of its BurstDR spinal cord stimulation devices for treating ...
USA Today

From chronic pain to 12,000 steps a day: Lynnette’s story of renewal

How Medtronic spinal cord stimulation therapy helped one woman reclaim her life. For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her ...